The best path forward isn’t always the same one you started down, which is why MedArrive is pivoting from delivering in-home care to “ClinOps orchestration for healthcare@home.”
MedArrive got its start at Redesign Health in 2020, powering care-at-home programs for payors and managed care groups by integrating physician-led telemedicine with in-home care from EMS professionals.
- Although MedArrive saw great results reducing ED usage and hospitalizations among the Medicaid populations that it worked with, the lackluster reimbursement meant that it would be a rough road to building a sustainable business.
- Instead of ignoring that economic reality and fueling visits with its $40M of VC funding, MedArrive decided to chart a new course where it could leverage its lived experience to enable other in-home providers to deliver better care.
To meet the needs of its own providers, MedArrive developed a comprehensive platform that handles:
- Patient and Labor Capacity Planning – models patient engagement and staffing needs
- Resource and Shift Management – ensures optimal labor use for anticipated visit volume
- Scheduling and Routing Optimization – maximizes utilization by minimizing driving
- Care Coordination – EHR-integration informs care planning and supports documentation
- Monitoring and Analytics – highlights critical efficiency, ROI, and clinical outcome levers
MedArrive is now focused on fine-tuning the tech infrastructure that it built for its own providers to meet the needs of other organizations looking to deliver high-quality in-home care.
- That’ll start by teaming up with other providers to co-develop new features and integrations to translate MedArrive’s own success to more partners, with full commercialization planned at some point over the next year.
The Takeaway
One of the best ways to get close to the problems of your end users is to spend time in their shoes, and it’s hard to get closer than MedArrive has by actually delivering in-home care. That experience should give MedArrive a leg up on competing platforms if it can help replicate its results with new partners.
